Homepage

  • AB Nexus announces new grant awards with a focus on research collaborations related to AI and climate change
    Today, the AB Nexus program announced its 2024 seed grant awards to interdisciplinary research teams from the University of baby直播app Anschutz Medical Campus and the University of baby直播app Boulder. Collectively, the seven winning teams will receive $713,000 in funding to advance cutting-edge research that improves human health and well-being.
  • From crisis to action: CU’s climate health champions in focus
    Jay Lemery, M.D. and Katherine James, Ph.D.鈥攂ased at the CU Anschutz Medical Campus鈥攖ogether with Jose-Luis Jimenez, Ph.D. at CU Boulder, epitomize the collaborative spirit of AB Nexus. While Lemery, James and Jimenez focus on distinct areas鈥攕uch as climate medicine, water contamination and airborne transmission鈥攁ll add to the collective efforts of climate adaptation and mitigation for baby直播app and global communities.

  • ARPA-H awards up to $39M for non-invasive osteoarthritis therapies
    鈥淭o truly address osteoarthritis, you have to get at both the biology and the structural problem,鈥 said co-Principal Investigator Michael Zuscik (Department of Orthopedics, CU Anschutz). 鈥淭his unique baby直播app dream team we have put together has the multidisciplinary expertise, and now the resources, to tackle both at once. We can approach curing the disease like never before.鈥
  • Joints that could heal themselves? Researchers could get there in 5 years
    The Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, the first created under ARPA-H, is enabling a dream team of engineers, medical scientists and veterinarians from CU Boulder, the CU Anschutz Medical Campus and baby直播app State University to make an aggressive final push toward a goal many have spent their entire careers pursuing.
  • AB Nexus transforming intercampus research collaboration after just three years
    The collaborative seed grant program will continue full steam ahead in Spring 2024, including the introduction of award tracks to seed research in two new, key areas of opportunity: Climate Change and Health; and Artificial Intelligence/Advanced Computing and Health.
  • New AB Nexus awardees advance innovative research collaborations
    From advancing new Alzheimer鈥檚 treatments to developing predictive computer models to help youth in crisis, newly awarded teams of researchers from the CU Anschutz Medical Campus and CU Boulder are advancing a wide range of collaborative research projects aimed at improving human health and well-being.听
  • Scientists pursue personalized approach to treating pelvic organ prolapse
    With vaginal birth a top cause of pelvic floor disorders, the conditions are common among women. But because the causes are multifactorial, complex and not completely understood, treatment lags. Two women scientists recently received an AB Nexus grant to help change that.
  • CU research team moves one step closer to printing models of life-like 3D organs
    A team of CU researchers funded by AB Nexus has developed a new strategy for transforming medical images, such as CT or MRI scans, into incredibly detailed 3D models on the computer. The advance marks an important step toward printing lifelike representations of human anatomy that medical professionals can squish, poke and prod in the real world.
  • New AB Nexus grant awards spotlight productive cross-campus collaborations
    The intercampus program stimulates innovative research collaborations and progress toward solving some of our world鈥檚 most pressing health problems. After receiving funding from the AB Nexus grant program, awarded teams have attracted $13 million in outside funding and published more than 20 peer-reviewed research studies.
  • Can AI detect Alzheimer’s earlier? Two researchers combine forces to find out
    With funding from AB Nexus, researchers from CU Anschutz and CU Boulder are developing an artificial intelligence tool with a goal of diagnosing dementia at earlier stages, so patients and providers can plan more effective treatment options.
Subscribe to Homepage